Quiero saber acerca de...

13392

Federal Register / Vol. 86, No. 43 / Monday, March 8, 2021 / Notices
must obtain approval from the Office of Management and Budget OMB for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
2. Evaluate the accuracy of the agencys estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses.
5. Assess information collection costs.
Proposed Project American Academy of Pediatrics AAP Resident Training on Children with Fetal Alcohol Spectrum Disorders FASDNewNational Center on Birth Defects and Developmental Disabilities NCBDDD, Centers for Disease Control and Prevention CDC.

Background and Brief Description Prenatal exposure to alcohol and other teratogens can have serious neurodevelopmental impact including Fetal Alcohol Spectrum Disorders FASD. FASD is an umbrella term that encompasses several, more specific, diagnoses. These conditions are associated with lifelong physical and neurodevelopmental abnormalities, including growth problems and prenatal brain damage. This brain damage may lead to developmental, behavioral and neurocognitive impairments. Infants with a FASD are rarely recognized at birth by hospital staff. Further, at later ages, these children may be overlooked or misdiagnosed. While there is no cure for FASDs, early identification and intervention can mitigate adverse effects.
In Bright Futures, the American Academy of Pediatrics AAP suggest routinely obtaining prenatal alcohol exposure history for all pediatric patients. The AAP also recommends developmental monitoring and screening for all patients for behavioral and neurodevelopmental issues.
Pediatricians are critical in the process of early identification, referral and ongoing care of children with FASDs.
Through regular well-child appointments, addressing parental concerns, and managing a familys pediatric medical home, pediatricians are in a key position to obtain and document prenatal exposure history to alcohol and other drugs. Relatedly, their role in monitoring development enables them to identify issues early that in turn facilitates timely treatment, especially early intervention. It is important for pediatricians to learn these skills early in their clinical training to make them routine throughout their clinical practice careers.
To facilitate and strengthen pediatricians role, with CDC funding, the American Academy of Pediatrics AAP has developed a curriculum and
program to provide first year pediatric resident trainees with strategies, tools and resources necessary for; 1
obtaining prenatal history of exposure to alcohol and other drugs for all their patients, 2 recognizing clinical manifestation of FASD in pediatric primary care settings to expedite diagnostic evaluation referrals, and 3
caring for affected children and their families in the pediatric medical home.
This program builds upon a pilot effort that was approved under GenIC
Clearance for CDC/ATSDR Formative Research and Tool Development title:
American Academy of Pediatrics Resident Training in Developmental Continuity Clinics with OMB Control Number 09201154.
The curriculum is presented in two phases. Phase One is a one-day, inperson, train-the-trainers session for attending physicians who oversee medical resident training in pediatrics.
Training will be provided by experts in identification, diagnosis and care of children with FASD. For Phase Two, the trainer attending physicians will implement a curriculum of continuing medical education activities with their first year pediatric residents. The curriculum contains both required and option activities that residents complete with support and facilitation from attending physicians. Evaluations are conducted only for required activities. It is estimated that 10 clinics will participate in the project which could include up to 10 attending physicians and an average of 25 pediatric residents per clinic 260 respondents/year.
Participant clinics are selected by a brief application to the AAP. All participation is voluntary. CDC requests approval for an estimated 32 annual burden hours. There is no cost to respondents other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Pediatricians

Attending physicians Screening & Diagnosis Pretest.
Attending physicians Screening & Diagnosis Posttest.
Attending physicians Treatment Across Lifespan Pretest.
Attending physicians Treatment Across Lifespan Posttest.
Attending physicians Overcoming Social Attitudes Pretest.
Attending physicians Overcoming Social Attitudes Posttest.

Pediatricians
jbell on DSKJLSW7X2PROD with NOTICES

Number of respondents
Type of respondents
Pediatricians
Pediatricians
Pediatricians
Pediatricians

VerDate Sep<11>2014

19:05 Mar 05, 2021

Jkt 253001

PO 00000

Frm 00114

Fmt 4703

Sfmt 4703

Burden per response hours
Number of responses
Burden in hours
10

1

10/60

2

10

1

10/60

2

10

1

10/60

2

10

1

10/60

2

10

1

10/60

2

10

1

10/60

2

E:FRFM08MRN1.SGM

08MRN1